ADAMS (A Disintegrins and Metalloproteinases) in the pathogenesis of asthma

D. Cataldo (Liege, Belgium)

Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis
Session: Regulation of lung inflammation and repair by proteolysis
Session type: Symposium
Number: 1956
Disease area: Airway diseases

Multimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Cataldo (Liege, Belgium). ADAMS (A Disintegrins and Metalloproteinases) in the pathogenesis of asthma. Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Matrix Metalloproteinases (MMPs) in patients with pulmonary tuberculosis (PT) and comorbid COPD
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

Matrix metalloproteinases (MMPs) and acute phase proteins (APP) in predicting the efficacy of intensive phase treatment (IPP) in patients with pulmonary tuberculosis (PT)
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016

Matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1(TIMP-1) as non-invasive biomarkers of remodelling in asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015

Expression of adamalysin proteases (A Disintegrin And Metalloprotease) and their inhibitors in sputum from asthmatics
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006

Matrix metalloproteinase (MMP) 12 is associated with clinical parameters of disease severity and exacerbations in asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2007; 30: Suppl. 51, 137s
Year: 2007

Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013

Late Breaking Abstract - Matrix metalloproteinases in serum and sputum reflect distinct processes of relevance to asthma
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019

Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008

Induced sputum (IS) MMP- 9 and TIMP- 1 in granulomatous diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Relationship between the Matrix Metalloproteinases (MMPs) levels and lung mechanic parameters established by impulse oscillometry (IOS) in patients with pulmonary tuberculosis (TB)
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020

Matrix metalloproteinases gene polymorphisms in the pathogenesis of primary spontaneous pneumothorax
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

Metalloproteinase-9 and tissue inhibitor of metalloproteinase in baker‘s asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 603s
Year: 2005

Matrix metalloproteinases in tuberculosis
Source: Eur Respir J 2011; 38: 456-464
Year: 2011

Lung overexpression of matrix metalloproteinase-2 protects against bronchial asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004

Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019

A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Source: Eur Respir J 2011; 38: 1200-1214
Year: 2011